Determined to bring savings to Australia’s Pharmaceutical Benefits Scheme, Samsung Bioepis and Organon have expanded their local partnership with a new undisclosed biosimilar product.
Determined to bring savings to Australia’s Pharmaceutical Benefits Scheme, Samsung Bioepis and Organon have expanded their local partnership with a new undisclosed biosimilar product.